SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001697884-21-000003
Filing Date
2021-04-14
Accepted
2021-04-14 11:35:16
Documents
47
Period of Report
2021-01-31

Document Format Files

Seq Description Document Type Size
1 vsbc10kjan2021.htm 10-K 526051
2 exhibit31.htm EX-31.1 7509
3 exhibit312.htm EX-31.2 7504
4 exhibit32.htm EX-32.1 8529
5 vsbc10kjan20211.jpg GRAPHIC 8501
6 vsbc10kjan20212.jpg GRAPHIC 8212
  Complete submission text file 0001697884-21-000003.txt   2156986

Data Files

Seq Description Document Type Size
7 none-20210131.xml EX-101.INS 455738
8 none-20210131.xsd EX-101.SCH 18219
9 none-20210131_cal.xml EX-101.CAL 5107
10 none-20210131_def.xml EX-101.DEF 17635
11 none-20210131_lab.xml EX-101.LAB 160824
12 none-20210131_pre.xml EX-101.PRE 88879
Mailing Address 2372 MORSE AVE. #950 IRVINE CA 92614
Business Address 2372 MORSE AVE. #950 IRVINE CA 92614 9492029235
VITASPRING BIOMEDICAL CO. LTD. (Filer) CIK: 0001697884 (see all company filings)

IRS No.: 371836726 | Fiscal Year End: 0131
Type: 10-K | Act: 34 | File No.: 333-216465 | Film No.: 21824917
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services